18 year follow up study suggests high mortality risk from untreated sleep disordered breathing
Moderate-to-severe sleep apnea is independently associated with increased risk of mortality
Treatment of obstructive sleep apnea with CPAP may lower cardiovascular risk
A study found 16% of Australian commercial drivers suffer from obstructive sleep apnea and 60% have sleep-disordered breathing.
Read more about sleep disordered breathing.

S8 AutoSet Spirit™ II
Latest APAP device. Featuring
Easy-Breathe Technology™
Mirage Activa™ LT
Unequalled comfort
VPAP™ IV
Noninvasive bilevel pressure support.
Compact, quiet and comfortable

Swift™ LT
Less is more.
VPAP™ III ST-A QuickNav
Large screen. Easier than ever
H4i™
Superior humidity output ... seamlessly integrated
International Diabetes Federation (IDF) makes statement supporting reciprocal screening of all patients with type 2 diabetes or sleep apnea.
Learn more about the link between OSA and type 2 diabetes.
Read the latest issue of Snooze Newz, our newsletter for people with sleep-disordered breathing (SDB) and their families. This issue focuses on getting the most out of your CPAP treatment.
Complete the Snooze Newz Readership Survey for your chance to win.
To get the most out of your treatment, read our FAQs.

Are you new to continuous positive airway pressure (CPAP) therapy or an existing user?
Become a member of sleepVantage to access information, support and expert advice
ResMed is a leading developer, manufacturer, and marketer of products for the diagnosis and treatment of sleep-disordered breathing.